PCH
INFI

Polar Capital Holdings’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Polar Capital Holdings’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,071,242
Closed -$1.15M – 328
2022
Q4 		$1.15M Sell
2,071,242
-2,928,758
-59% -$2.49M 0.01% 274
2022
Q3 		$5.95K Hold
5,000,000
– – 0.04% 234
2022
Q2 		$3.16K Hold
5,000,000
– – 0.02% 261
2022
Q1 		$5.7K Hold
5,000,000
– – 0.03% 257
2021
Q4 		$11.3K Buy
5,000,000
+2,500,000
+100% +$6.28M 0.04% 219
2021
Q3 		$8.55K Buy
+2,500,000
New +$7.71M 0.03% 245

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Polar Capital Holdings's INFI Position: Q1 2023 in Review

Polar Capital Holdings sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2023, closing a stake of 2,071,242 shares — an estimated $1.15M sold.

Polar Capital Holdings first reported a position in INFI in Q3 2021 and held it in 6 quarters. The position peaked at $1.15M in Q4 2022. 53 funds tracked by Wall St. Rank hold INFI as of Q1 2023.

  • Polar Capital Holdings reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Polar Capital Holdings sold 2,071,242 Infinity Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.15M.
  • Polar Capital Holdings first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 6 quarters.
  • Polar Capital Holdings's Infinity Pharmaceuticals, Inc. position peaked at $1.15M in Q4 2022.
  • 53 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2023.

Based on Polar Capital Holdings's 13F filing for Q1 2023, filed 15 May 2023.